nitroglycerin has been researched along with Infection in 2 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Infections were associated with an increased risk of death (p < 0." | 2.84 | Infections Up to 76 Days After Stroke Increase Disability and Death. ( Bath, PM; Bereczki, D; Berge, E; Caso, V; Christensen, H; Collins, R; Czlonkowska, A; El Etribi, A; Farr, TD; Fone, KC; Gommans, J; Laska, AC; Learoyd, AE; Ntaios, G; Ozturk, S; Pocock, SJ; Prasad, K; Shaw, L; Sprigg, N; Trueman, RC; Wardlaw, JM; Woodhouse, L, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Learoyd, AE | 1 |
| Woodhouse, L | 1 |
| Shaw, L | 1 |
| Sprigg, N | 1 |
| Bereczki, D | 1 |
| Berge, E | 1 |
| Caso, V | 1 |
| Christensen, H | 1 |
| Collins, R | 1 |
| Czlonkowska, A | 1 |
| El Etribi, A | 1 |
| Farr, TD | 1 |
| Gommans, J | 1 |
| Laska, AC | 1 |
| Ntaios, G | 1 |
| Ozturk, S | 1 |
| Pocock, SJ | 1 |
| Prasad, K | 1 |
| Wardlaw, JM | 1 |
| Fone, KC | 1 |
| Bath, PM | 1 |
| Trueman, RC | 1 |
| Wang, P | 1 |
| Ba, ZF | 1 |
| Chaudry, IH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Collaborative, International, Multicentre, Randomised, Parallel-group, Single and Outcome Blinded, Controlled, Factorial Trial to Investigate the Safety and Efficacy of Treatment With Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, a[NCT00989716] | Phase 3 | 3,500 participants (Anticipated) | Interventional | 2001-07-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for nitroglycerin and Infection
| Article | Year |
|---|---|
Infections Up to 76 Days After Stroke Increase Disability and Death.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Incidence; Infections; Male; Middle Aged; Nitroglyce | 2017 |
1 other study available for nitroglycerin and Infection
| Article | Year |
|---|---|
Endothelium-dependent relaxation is depressed at the macro- and microcirculatory levels during sepsis.
Topics: Acetylcholine; Animals; Aorta; Arginine; Endothelium, Vascular; In Vitro Techniques; Infections; Int | 1995 |